Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Recruiting 2Active not recruiting 2Suspended 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5

Conditions

Polycystic Ovary Syndrome 21Glioblastoma 5Endometrial Neoplasms 5Breast Neoplasms 5Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Leukoplakia, Oral 3Insulin Resistance 3Ovarian Neoplasms 2Metabolic Syndrome 2Metabolic Diseases 2Medulloblastoma 2Infertility 2Erythroplasia 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Adenocarcinoma Of Esophagus 2Weight Loss 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Thyroid Diseases 1TP53 Y220C Mutation 1Smoldering Multiple Myeloma 1Sarcoma 1Rectal Neoplasms 1Prostate Cancer Recurrent 1Prediabetic State 1Posterior Fossa Ependymal Tumor 1Pleural Effusion, Malignant 1

Interventions

Temozolomide 100Radiotherapy 49Magnetic Resonance Spectroscopy 38Radiation 28Specimen Handling 25pembrolizumab 22Bevacizumab 22Lomustine 16Nivolumab 14Surgical Procedures, Operative 10atezolizumab 8Cyclophosphamide 8Biopsy 8abemaciclib 7Ipilimumab 7fludarabine 6Radiotherapy, Intensity-Modulated 6Carboplatin 6Aminolevulinic Acid 6olaparib 5Metformin 5Drug Therapy 5Diet, Ketogenic 5Dianhydrogalactitol 5poly ICLC 4cemiplimab 4Radiosurgery 4Photons 4Leukapheresis 4Immunoglobulin G 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Glioblastoma × Metformin × 1 year × Clear all
NCT04691960 2025-12-19

A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging

Weill Medical College of Cornell University

Phase 2 Active not recruiting
18 enrolled
CNS

Glioblastoma

NCT05183204 2025-12-18

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Weill Medical College of Cornell University

Phase 2 Suspended
33 enrolled
CNS

Glioblastoma

NCT04945148 2025-11-21

OPTIMUM

Hopital Foch

Phase 2 Recruiting
640 enrolled
CNS

Glioblastoma

NCT05929495 2025-07-25

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

University of Milano Bicocca

Phase 2 Recruiting
25 enrolled
CNS

Glioblastoma, Glioma, Neoplasms

NCT02780024 2025-06-26

Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Active not recruiting
50 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡